AI
EPZM

Atom Investors’s Epizyme, Inc EPZM Stock Holding History

Atom Investors’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-122,517
Closed -$1.97M – 669
2020
Q2 		$1.97M Sell
122,517
-126,108
-51% -$2.2M 0.21% 137
2020
Q1 		$3.86M Buy
248,625
+2,022
+0.8% +$43.4K 0.39% 72
2019
Q4 		$6.07M Buy
246,603
+4,959
+2% +$73.6K 0.51% 65
2019
Q3 		$2.49M Buy
241,644
+47,550
+24% +$600K 0.19% 143
2019
Q2 		$2.44M Buy
+194,094
New +$2.5M 0.16% 171

Other funds holding EPZM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return